These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
11. A new strategy for the application of CA19-9 in the differentiation of pancreaticobiliary cancer: analysis using a receiver operating characteristic curve. Kim HJ, Kim MH, Myung SJ, Lim BC, Park ET, Yoo KS, Seo DW, Lee SK, Min YI. Am J Gastroenterol; 1999 Jul; 94(7):1941-6. PubMed ID: 10406263 [Abstract] [Full Text] [Related]
13. [Significance of detection of K-ras gene mutations and CA19-9 in serum for diagnosis of pancreatic carcinoma]. Zhang Y, Ji SR, Feng DX, Ji J, Han TQ. Ai Zheng; 2003 Mar; 22(3):295-7. PubMed ID: 12654190 [Abstract] [Full Text] [Related]
15. [Value of serum CA 19-9 determination in the diagnosis of pancreatic carcinoma]. Pei DP. Zhonghua Wai Ke Za Zhi; 1990 Oct; 28(10):625-7, 638-9. PubMed ID: 2086060 [Abstract] [Full Text] [Related]